Research/art/teacher profile of a person
Name and surname:
doc. MUDr. Tomáš Bolek, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Bolek
I.2 - Name
Tomáš
I.3 - Degrees
Assoc.prof., MD, PhD
I.4 - Year of birth
1991
I.5 - Name of the workplace
Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, CU in Bratislava
I.6 - Address of the workplace
Kollárova 2, 036 59 Martin
I.7 - Position
associate professor
I.8 - E-mail address
ato.bolek@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/33249
I.10 - Name of the study field in which a person works at the university
General Medicine
I.11 - ORCID iD
0000-0003-0242-3317

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2015
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2020
II.c - Study field and programme
Internal Medicine (PhD.)
II.4 - Associate professor
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2024
II.c - Study field and programme
Internal Medicine
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Secondary Doctor University hospital in Martin 2015 -
assistant Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2020 -
asociate profesor Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2024 -

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Specialization in Internal Medicine Jessenius Faculty of Medicine in Martin, Comenius Universtiy in Bratislava 2020

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Propedeutics of Internal Medicine General Medicine I.+II. General Medicine
Internal Medicine 1 - 5 General Medicine I.+II. General Medicine
Propedeutics of Internal Medicine Dentistry, Dental Medicine I.+II. Dentistry, Dental Medicine
Internal Medicine 1 - 4 Dentistry, Dental Medicine I.+II. Dentistry, Dental Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
2
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Diploma Thesis Semminar 1 - 3 General Medicine I.+II. General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
118
VI.1.b - Over the last six years
118
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
36
VI.1.b - Over the last six years
36
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
100
VI.1.b - Over the last six years
100
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
100
VI.1.b - Over the last six years
100
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
1
VI.1.b - Over the last six years
1
VI.2 - The most significant research/artistic/other outputs
1

Bolek T, Samoš M, Stančiaková L, Ivanková J, Škorňová I, Staško J, Galajda P, Kubisz P, Mokáň M. The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation. Am J Ther 2019; 26: e308-e313. ADC, IF (JCR 2016) 1,588.

2

Bolek T, Samoš M, Škorňová I, Stančiaková L, Staško J, Galajda P, Kubisz P, Mokáň M.CDabigatran Levels in Elderly Patients with Atrial Fibrillation: First Post Marketing Experiences. Drugs Aging 2018; 35: 539 – 544. ADC, IF (JCR 2016) 2,381.

3

Bolek T, Samoš M, Škorňová I, Stančiaková L, Staško J, Korpallová B, Galajda P, Kubisz P, Mokáň M. Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treatedCpatients with atrial fibrillation? A pilot study. J Thromb Thrombolysis 2019; 47: 140 - 145. ADC, IF (JCR 2019) 2,054.

4

Samoš M, Fedor M, Kovář F, Galajda P, Bolek T, Stančiaková L, Fedorová J, Staško J, Kubisz P, Mokáň M. The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study. J Diabetes Res 2016; 2016:

2909436. ADM, IF (JCR 2016) 2,717.

5

Bolek T, Samoš M, Škorňová I, Schnierer M, Lipták P, Bánovčin P, Urban L, Staško J, Kubisz P, Galajda P, Mokán M. Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference? Eur J Clin Pharmacol 2019; 75: 875 - 877.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Bolek T, Samoš M, Stančiaková L, Ivanková J, Škorňová I, Staško J, Galajda P, Kubisz P, Mokáň M. The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation. Am J Ther 2019; 26: e308-e313. ADC, IF (JCR 2016) 1,588.

2

Bolek T, Samoš M, Škorňová I, Stančiaková L, Staško J, Galajda P, Kubisz P, Mokáň M.CDabigatran Levels in Elderly Patients with Atrial Fibrillation: First Post Marketing Experiences. Drugs Aging 2018; 35: 539 – 544. ADC, IF (JCR 2016) 2,381.

3

Bolek T, Samoš M, Škorňová I, Stančiaková L, Staško J, Korpallová B, Galajda P, Kubisz P, Mokáň M. Does proton pump inhibition change the on-treatment anti-Xa activity in xabans-treatedCpatients with atrial fibrillation? A pilot study. J Thromb Thrombolysis 2019; 47: 140 - 145. ADC, IF (JCR 2019) 2,054.

4

Samoš M, Fedor M, Kovář F, Galajda P, Bolek T, Stančiaková L, Fedorová J, Staško J, Kubisz P, Mokáň M. The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study. J Diabetes Res 2016; 2016:

2909436. ADM, IF (JCR 2016) 2,717.

5

Bolek T, Samoš M, Škorňová I, Schnierer M, Lipták P, Bánovčin P, Urban L, Staško J, Kubisz P, Galajda P, Mokán M. Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference? Eur J Clin Pharmacol 2019; 75: 875 - 877.


VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Chan, N. C. - Coppens, M. - Hirsh, J. - Ginsberg, J. S. - Weitz, J. I. - Vanassche, T. - Douketis, J. D. - Schulman, S. - Eikelboom, J. W.: Journal of Thrombosis and Haemostasis, roč. 13, č. 3, 2015, s. 353-359 - SCI ; SCOPUS

2

Douketis, J. D. - Wang, G. - Chan, N. - Eikelboom, J. W. - Syed, S. - Barty, R. - Moffat, K. A. - Spencer, F. A. - Blostein, M. - Schulman, S.: Journal of Thrombosis and Haemostasis, roč. 14, č. 1, 2016, s. 89-97 - SCI ; SCOPUS

3

Warkentin, T. E. - Pai, M. - Linkins, L. A.: Blood, roč. 130, č. 9, 2017, s. 1104-1113 - SCI ; SCOPUS

4

Wang, N. - Chen, L. - Li, N. - Xu, G. - Qi, F. - Zhu, L. - Liu, W.: Scientific Reports, roč. 10, č. 1, 2020, čl. č. 9717 - SCI ; SCOPUS

5

Shin, H. J. - Boo, G. - Na, H. S.: Journal of Anesthesia, roč. 35, č. 5, 2021, s. 633-637 - SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV 16-00-20 Specific laboratory monitoring of platelets reactivity in patients with acute myocardial infarction treated by new antagonists of P2Y12 receptors (Co-Investigator)

2

VEGA 1/0549/19 Applications of results of DNA analyse and microRNA detection in primary and secondary proplylaxis of thromboembolic complications in patients with sticky platelet syndrome (Co-Investigator).

3

VEGA 1/0090/20 (2020 – 2022) New trends in treatment and new markers of progression of chronic heart disease with preserved ejection function im patients with type 2 diabetes mellitus. Research of risk factors of chronic heart failure with preserved ejection fraction in patients with obesity and type 2 diabetes mellitus (Co-Investigator).

4

European Structural and Investment Funds  ITMS2014+:313011V344 (2019 – 2023) Long-term strategic research of prevention, intervention and mechanisms of obesity and its comorbidities. Activity – Mechanisms and markers of obesity and its comorbidities – research of microRNA as biomarkers (Co-investigator).

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-20